Vascular heparan sulfates may limit the ability of leukocytes to penetrate the endothelial barrier — implications for use of glucosamine in inflammatory disorders
To access this article, please choose from the options below
PII: S0306-9877(98)90247-X
© 1998 Published by Elsevier Inc.
